Managing Principal/Partner & Lead: Global Health Economics & Outcomes Research at ZS Associates
Greater Los Angeles Area
My career is a synergy of advanced people skills with advanced technical skills. With people, I work to elicit diverse and articulate input, build consensus, and share information on complex issues in a comprehensible manner for international stakeholders and audiences. From a technical side, my goal is to bring the most rigorous, accurate, and widely received methods...
My career is a synergy of advanced people skills with advanced technical skills. With people, I work to elicit diverse and articulate input, build consensus, and share information on complex issues in a comprehensible manner for international stakeholders and audiences. From a technical side, my goal is to bring the most rigorous, accurate, and widely received methods available in a manner that makes them accessible to all parties involved. Specialties:Management of, and collaboration with, internal and external experts in the persuit of collaborative goals. I am an expert on building and maintaing international relationships, business development, staff management and development, workshops and presentations. Patient reported outcomes development, use/selection, interpretation, and dossiers; all psychometrics snd statistical analysis; HEOR planning and study execution.Executive Director & Lead: Global Health Economics & Outcomes Research @ As part of the Real World Outcomes, GHEOR efforts at PPD are intended to support a panoply of services for real world outcomes and late stage research. I will oversee the growth of this group at PPD and be charged with development of the strategy and achievement of broad goals to serve internal and client needs. From September 2014 to Present (1 year 2 months) Greater Los Angeles AreaSenior Director & Lead: Patient Reported Outcomes Group @ Our PRO Group is part of Covance's Market Access division, Global Health Economics & Outcomes Research group. I lead a growing and international group of PRO experts in charge of advancing Covance's breadth and depth of patient ported outcomes (PROs) consulting repertoire. Three PRO specialty areas report to me: PRO Clinical Trial Strategy & Execution, PRO Development & Validation, and ePRO Consulting. In concert with the leadership of GHEOR, I direct the development of the vision, strategy, and tactical execution for PRO strategies around the globe for our group. In this manner, I am also in charge of directing the BD efforts for the group and helping to ensure our prospective studies group and the PRO group interact with other Covance divisions (e.g., clinical development services) to ensure BD and project support are provided. I also serve as an internal and regulatory expert on PRO matters, as projects dictate. From December 2013 to September 2014 (10 months) Greater San Diego AreaDirector, Lead: Patient Reported Outcomes Group @ As part of the Covance’s Market Access (CMA) group, I am in charge of advancing Covance's breadth and depth of patient reported outcomes (PROs) consulting repertoire. I provide KOL-level input on psychometrics, advanced statistics, power analyses, PRO dossiers, and other PRO-related consulting. In addition to overseeing many of the PRO-related projects, I am also an integral part of the business-development team striving to expand relationships with current Covance clients and establish new relationships for CMA. As part of business development, I clarify CMA’s unique capabilities and services, draw attention to our signature client service, and develop proposals with integrated consulting throughout CMA’s health economic and outcomes research and all of Covance. From November 2009 to December 2013 (4 years 2 months) Adjunct Professor @ I taught Advanced Statistics II for doctoral students enrolled in the industrial/organizational psychology program at MGSM. The class covered factor analysis (EFA, CFA), advanced regression, logistic and loglinear analyses, missing data techniques, and power analysis. From August 2007 to December 2009 (2 years 5 months) Denosumab Oncology, Global Health Economics @ I was responsible for multiple aspects of value evidence generation in support of denosumab’s value propositions in the oncology indications, focusing on patient reported outcomes, health utilities, retrospective database analyses, and observational research. The phase 3 and 4 goals I oversaw primarily involved the delay of bone metastasis, including overseeing development of the global value dossier, development of disease specific utilities, meta-analysis of various data sources, development of the cost-effectiveness and budget-impact model, and overall planning for the direction of this indication. I also served as an internal expert on all matters of patient-reported outcomes, longitudinal modeling, power analysis, and missing data issues, including to various internal review boards, biostats, a special R&D-wide group on translation services reform, and throughout the GHE department. From December 2008 to 2009 (1 year) President & Senior Research Scientist @ As a senior research scientist, I have been primarily involved in planning/overseeing outcomes projects. I have been the lead scientist on: dozens of development and validation projects for outcomes measures; several complex economic modeling projects (cost-effectiveness, price elasticity, and larger macroeconomic models); scores of analysis and publication/dissemination of outcomes data; consulting on regulatory issues related to dossiers and SAPs; and much more. As president, I oversee all issues related to team building, forecasting and tracking of economic of institutional goals, reporting to our board of directors, development and adherence of SOPs, and more. From June 1999 to December 2008 (9 years 7 months) Director & Senior Scientist @ I was the director of business development (BD) for, and senior scientist in, QualityMetric’s External Science division. As a director of BD, I acted as a scientific liaison in this role, helping clients understand the array of services available to them given their project needs and timelines. I also provided scientific review of strengths and weaknesses for various project approaches in light of their particular needs. Finally, I oversaw the proposal development and ensure it captures the client’s needs accurately with a budget and timeline that were appropriate for all parties. As a senior scientist, I conducted and supervised team personnel in the design and implementation of statistical, methodological, and scientific plans for client research in health outcomes. Studies I oversaw include FDA Phase 2-4 clinical trials (and related international regulatory agencies), including power analyses, study design, analysis planning, label claim planning and dossiers, PRO development and validation, and clinical trial analyses. My expertise was used in all health outcomes, including use and development of PROs, the complete label claims pursuit process from initial planning to dossier submission and postmarketing activities, planning and interpreting economic modeling, and navigating through the various differences between international governmental regulatory agencies. I also oversaw various statistical techniques (both designing SAPs and conducting/interpreting results), including variants of structural equation modeling, advanced missing data handling, item response theory, various forms of longitudinal analyses, nonparametric analyses, and logistic and parametric regression. My duties also included much writing for peer-reviewed publication and presentation. Additionally, I was in charge of in-house training for statistics and measurement at QualityMetric’s consulting division. From August 2004 to September 2008 (4 years 2 months) Senior Statistician @ As a Senior Statistician for the Cousins Center for Psychoneuroimmunology, my responsibilities were both research-oriented and supervisory (Center Director: Michael Irwin, MD). Along with the supervision of statistics personnel, I designed and implemented statistical plans for grant-funded research in PNI including latent growth curve modeling, standard and multigroup structural modeling, item response theory, and various forms of repeated measures analyses. My duties also included providing statistical consultation for investigators throughout our center and affiliated groups as well as much writing for academic publication From July 2002 to August 2004 (2 years 2 months) PhD, Clinical Psychology @ CSPP From 1994 to 2000 MA, Clinical Psychology @ CSPP From 1994 to 1996 BA, Psychology @ University of California, Irvine From 1992 to 1994 Jason PhD is skilled in: Cross-functional Team..., Health Economics and..., Outcomes Research, Health Economics, Outcomes, Statistics, Health Outcomes, Research, Patient Reported..., Patient Outcomes, Meta-analysis, Data Analysis, Clinical Study Design, Global Health, Regulatory Submissions, Research Design, Clinical Trials, Market Access, Management, Strategy, International Research, Clinical Research, Pharmaceutical Industry, Drug Development, Health Policy, Biostatistics, Analysis, Epidemiology, Oncology, EDC, Biotechnology, CRO
Executive Director & Lead: Global Health Economics & Outcomes Research
September 2014 to Present
Greater Los Angeles Area
Covance Market Access
Senior Director & Lead: Patient Reported Outcomes Group
December 2013 to September 2014
Greater San Diego Area
Covance Market Access
Director, Lead: Patient Reported Outcomes Group
November 2009 to December 2013
Marshall Goldsmith School of Management
August 2007 to December 2009
Denosumab Oncology, Global Health Economics
December 2008 to 2009
Consulting Measurement Group
President & Senior Research Scientist
June 1999 to December 2008
Director & Senior Scientist
August 2004 to September 2008
UCLA Cousins Centers for Psychoneuroimmunology
July 2002 to August 2004
As part of the Real World Outcomes, GHEOR efforts at PPD are intended to support a panoply of services for real world outcomes and late stage research. I will oversee the growth of this group at PPD and be charged with development of the strategy and achievement of broad goals to serve internal and client needs. As part of the Real World Outcomes, GHEOR efforts at PPD are intended to support a panoply of services for real world outcomes and late stage research. I will oversee the growth of this group at PPD and be charged with development of the strategy and achievement of broad goals to serve internal and client needs.
What company does Jason PhD work for?
Jason PhD works for PPD
What is Jason PhD's role at PPD?
Jason PhD is Executive Director & Lead: Global Health Economics & Outcomes Research
What industry does Jason PhD work in?
Jason PhD works in the Biotechnology industry.
Enjoy unlimited access and discover candidates outside of LinkedIn
One billion email addresses and counting
Everything you need to engage with more prospects.
ContactOut is used by
76% of Fortune 500 companies